Guest: Thomas J. Weber, MD

CME Information FacultyThomas J. Weber, MDAssociate Professor of MedicineDivision of Endocrinology, Metabolism and NutritionDuke University Medical CenterDurham, NC Activity PlannersChristie Avraamides, PhDClinical Content ManagerMed-IQBaltimore, MD Lisa R. Rinehart, MS, ELSDirector, Editorial ServicesMed-IQBaltimore, MD Amy SisonDirector of Continuing Medical EducationMed-IQBaltimore, MD WriterKatherine Stevens-Favorite, PhDMontpelier, VT Activity OverviewThis CME online publication reviews the diagnosis and management of patients with primary hyperparathyroidism (PHPT). It explores guideline-based approaches for assessing and managing patients with asymptomatic PHPT, including a discussion on clinical presentation, evaluation for asymptomatic PHPT, and surgical and medical management. Learning ObjectivesUpon completion, participants should be able to: Identify patients with primary hyperparathyroidism Understand the clinical indications for surgical referral in patients with primary hyperparathyroidism Understand medical treatment options for patients with primary hyperparathyroidism Target AudienceThis activity is intended for physicians, nurse practitioners, physician assistants, nurses, and pharmacists. Statement of NeedPrimary hyperparathyroidism (PHPT) is the most common hypercalcemic disorder, present in 1% of the general adult population. This disorder can have broad physiologic effects, including reduced bone density, nephrolithiasis, cardiovascular dysfunction, and sometimes neurologic symptoms. For many years, PHPT was diagnosed by the presentation of these symptoms, most commonly renal calculi and/or osteoporosis with fractures. However, the broad implementation of biochemical panels in ...